Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Psychiatric patients have a greater risk of premature mortality, predominantly due to cardiovascular diseases (CVDs). Convincing evidence shows that psychiatric conditions are characterized by an increased risk of metabolic syndrome (MetS), a clustering of cardiovascular risk factors including dyslipidemia, abdominal obesity, hypertension, and hyperglycemia. This increased risk is present for a range of psychiatric conditions, including major depressive disorder (MDD), bipolar disorder (BD), schizophrenia, anxiety disorder, attention-deficit/hyperactivity disorder (ADHD), and posttraumatic stress disorder (PTSD). There is some evidence for a dose-response association with the severity and duration of symptoms and for a bidirectional longitudinal impact between psychiatric disorders and MetS. Associations generally seem stronger with abdominal obesity and dyslipidemia dysregulations than with hypertension. Contributing mechanisms are an unhealthy lifestyle and a poor adherence to medical regimen, which are prevalent among psychiatric patients. Specific psychotropic medications have also shown a profound impact in increasing MetS dysregulations. Finally, pleiotropy in genetic vulnerability and pathophysiological mechanisms, such as those leading to the increased central and peripheral activation of immunometabolic or endocrine systems, plays a role in both MetS and psychiatric disorder development. The excess risk of MetS and its unfavorable somatic health consequences justifies a high priority for future research, prevention, close monitoring, and treatment to reduce MetS in the vulnerable psychiatric patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Abnormal LDL levels have been reported to be associated with multiple medical commodities in UPD and bipolar disorder, such as metabolic syndrome and vascular disease63,64.”
From Optimizing multi-domain hematologic biomarkers and clinical features for the differential diagnosis of unipolar depression and bipolar depression (2023) · doi:10.1038/s44184-023-00024-z · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Self-citationRisks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,082
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Lithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 877
Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Self-citationExercise as a treatment for depression: A meta-analysis
Kvam, S., Kleppe, C. L., Nordhus, I. H., & Hovland, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.063 · Cited by 837
Bidirectional Association Between Depression and Metabolic Syndrome
Pan, A., Keum, N., Okereke, O. I., Sun, Q., Kivimaki, M., Rubin, R. R., & Hu, F. B. (2012) · Diabetes Care · doi:10.2337/dc11-2055 · Cited by 772
Church, T. S., Earnest, C. P., Skinner, J. S., & Blair, S. N. (2007) · JAMA · doi:10.1001/jama.297.19.2081 · Cited by 756
Rosenbaum, S., Tiedemann, A., Sherrington, C., Curtis, J., & Ward, P. B. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08765 · Cited by 692
Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis
Serretti, A., & Mandelli, L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05346blu · Cited by 621
Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms
Penninx, B. W. J. H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.07.003 · Cited by 576
Self-citationLithium toxicity profi le: a systematic review and meta-analysis
McKnight, R. F., Budge, K., Ba, S., Goodwin, G. M., Geddes, J. R., & Adida, M. (2012) · Cited by 544
Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer, J. W. (2007) · PubMed · Cited by 478
Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis
Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3803 · Cited by 457
Vancampfort, D., Vansteelandt, K., Correll, C. U., Mitchell, A. J., De Herdt, A., Sienaert, P., Probst, M., & De Hert, M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050620 · Cited by 441
Anxiety and new onset of cardiovascular disease: critical review and meta-analysis
Batelaan, N. M., Seldenrijk, A., Bot, M., van Balkom, A. J. L. M., & Penninx, B. W. J. H. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156554 · Cited by 362
Self-citationAmare, A. T., Schubert, K. O., Klingler-Hoffmann, M., Cohen-Woods, S., & Baune, B. T. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.261 · Cited by 345
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332
van Rossum, E. F. C., Koper, J. W., Huizenga, N. A. T. M., Uitterlinden, A. G., Janssen, J. A. M. J. L., Brinkmann, A. O., Grobbee, D. E., de Jong, F. H., van Duyn, C. M., Pols, H. A. P., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3128 · Cited by 329
Licht, C. M. M., de Geus, E. J. C., Seldenrijk, A., van Hout, H. P. J., Zitman, F. G., van Dyck, R., & Penninx, B. W. J. H. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.126698 · Cited by 319
Self-citationVancampfort, D., Wampers, M., Mitchell, A. J., Correll, C. U., De Herdt, A., Probst, M., & De Hert, M. (2013) · World Psychiatry · doi:10.1002/wps.20069 · Cited by 317
Associations Between Anxiety, Depression, and the Metabolic Syndrome
Skilton, M. R., Moulin, P., Terra, J.-L., & Bonnet, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.012 · Cited by 312
Henderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288
Shelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 261
Correll, C. U., Sheridan, E. M., & DelBello, M. P. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00798.x · Cited by 255
Rosenbaum, S., Stubbs, B., Ward, P. B., Steel, Z., Lederman, O., & Vancampfort, D. (2015) · Metabolism · doi:10.1016/j.metabol.2015.04.009 · Cited by 246
Lopresti, A. L., & Drummond, P. D. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.005 · Cited by 231
de Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., & Hanwella, R. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1049-5 · Cited by 227
Longitudinal Evidence for Unfavorable Effects of Antidepressants on Heart Rate Variability
Licht, C. M. M., de Geus, E. J. C., van Dyck, R., & Penninx, B. W. J. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.032 · Cited by 225
Self-citationRojo, L. E., Gaspar, P. A., Silva, H., Risco, L., Arena, P., Cubillos-Robles, K., & Jara, B. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.022 · Cited by 218
Lasserre, A. M., Glaus, J., Vandeleur, C. L., Marques-Vidal, P., Vaucher, J., Bastardot, F., Waeber, G., Vollenweider, P., & Preisig, M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.411 · Cited by 215
Rosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199
Van Reedt Dortland, A. K. B., Giltay, E. J., Van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01565.x · Cited by 191
Self-citationPolygenic dissection of major depression clinical heterogeneity
Milaneschi, Y., Lamers, F., Peyrot, W. J., Abdellaoui, A., Willemsen, G., Hottenga, J.-J., Jansen, R., Mbarek, H., Dehghan, A., Lu, C., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.86 · Cited by 184
Self-citationInflammation in schizophrenia: A question of balance
Leza, J. C., García-Bueno, B., Bioque, M., Arango, C., Parellada, M., Do, K., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 182
Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Leung, J. Y. T., Barr, A. M., Procyshyn, R. M., Honer, W. G., & Pang, C. C. Y. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.04.003 · Cited by 163
Medical comorbidity in bipolar disorder: reprioritizing unmet needs
McIntyre, R. S., Soczynska, J. K., Beyer, J. L., Woldeyohannes, H. O., Law, C. W., Miranda, A., Konarski, J. Z., & Kennedy, S. H. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281938102 · Cited by 140
Mitchell, A. J., Lord, O., & Malone, D. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.094532 · Cited by 136
Vogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.9 · Cited by 133
Self-citationVan Citters, A. D., Pratt, S. I., Jue, K., Williams, G., Miller, P. T., Xie, H., & Bartels, S. J. (2010) · Community Mental Health Journal · doi:10.1007/s10597-009-9272-x · Cited by 131
Tang, F., Wang, G., & Lian, Y. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.025 · Cited by 117
Malan‐Müller, S., Kilian, S., van den Heuvel, L. L., Bardien, S., Asmal, L., Warnich, L., Emsley, R. A., Hemmings, S. M. J., & Seedat, S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.011 · Cited by 112
Autism Spectrum Disorders and Metabolic Complications of Obesity
Shedlock, K. E., Susi, A., Gorman, G. H., Hisle-Gorman, E. J., Erdie-Lalena, C. R., & Nylund, C. M. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.07.055 · Cited by 109
The prevalence of metabolic syndrome in alcohol use disorders: a systematic review and meta-analysis
Vancampfort, D., Hallgren, M., Mugisha, J., De Hert, M., Probst, M., Monsieur, D., & Stubbs, B. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agw040 · Cited by 107
Carney, R., Cotter, J., Bradshaw, T., Firth, J., & Yung, A. R. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.010 · Cited by 104
Moreira, F. P., Jansen, K., Cardoso, T. D. A., Mondin, T. C., Magalhães, P. V. D. S., Kapczinski, F. P., Souza, L. D. D. M., da Silva, R. A., Oses, J. P., & Wiener, C. D. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.025 · Cited by 104
Paz-Filho, G., Wong, M.-L., & Licinio, J. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02536.x · Cited by 103
Hiles, S. A., Révész, D., Lamers, F., Giltay, E., & Penninx, B. W. J. H. (2016) · Depression and Anxiety · doi:10.1002/da.22512 · Cited by 103
Self-citationAnxiety disorders and risk of stroke: A systematic review and meta-analysis
Pérez-Piñar, M., Ayerbe, L., González, E., Mathur, R., Boreu, Q. F., & Ayis, S. A. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.11.004 · Cited by 103
Vogelzangs, N., Beekman, A. T. F., Boelhouwer, I. G., Bandinelli, S., Milaneschi, Y., Ferrucci, L., & Penninx, B. W. J. H. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06559 · Cited by 100
Self-citationPérez-Piñar, M., Mathur, R., Foguet, Q., Ayis, S., Robson, J., & Ayerbe, L. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.02.004 · Cited by 96
Butnorienė, J., Bunevičius, A., Norkus, A., & Bunevičius, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.002 · Cited by 86
Structure of major depressive disorder in adolescents and adults in the US general population
Lamers, F., Burstein, M., He, J.-P., Avenevoli, S., Angst, J., & Merikangas, K. R. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.098079 · Cited by 80
Metabolic syndrome and obsessive–compulsive disorder: a naturalistic Italian study
Albert, U., Aguglia, A., Chiarle, A., Bogetto, F., & Maina, G. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.10.004 · Cited by 79
Depression, anxiety and incident cardiometabolic diseases
Scott, K. M. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000067 · Cited by 77
Attention-Deficit/Hyperactivity Disorder and Adverse Health Outcomes in Adults
Spencer, T. J., Faraone, S. V., Tarko, L., McDermott, K., & Biederman, J. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000191 · Cited by 75
Kahl, K. G., Greggersen, W., Schweiger, U., Cordes, J., Correll, C. U., Frieling, H., Balijepalli, C., Lösch, C., & Moebus, S. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0339-2 · Cited by 73
Etiology of cardiovascular disease in patients with schizophrenia: current perspectives
Emül, M., & Kalelioğlu, T. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s50006 · Cited by 73
Sublette, M. E., & Postolache, T. T. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318268de9f · Cited by 72
Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications
Fonseka, T. M., Müller, D. J., & Kennedy, S. H. (2016) · Complex Psychiatry · doi:10.1159/000441521 · Cited by 64
Metabolic dysregulation and late-life depression: a prospective study
Marijnissen, R. M., Vogelzangs, N., Mulder, M., van den Brink, R. H. S., Comijs, H. C., & Voshaar, R. C. O. (2016) · Psychological Medicine · doi:10.1017/s0033291716003196 · Cited by 64
Šilarova, B., Giltay, E. J., Dortland, A. K. B. V. R., van Rossum, E. F. C., Hoencamp, E., Penninx, B. W. J. H., & Spijker, A. T. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.02.010 · Cited by 60
Self-citationNash, A. I. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.07.010 · Cited by 55
Assessment of Insulin Resistance and Metabolic Syndrome in Drug Naive Patients of Bipolar Disorder
Guha, P., Bhowmick, K., Mazumder, P., Ghosal, M. K., Chakraborty, I., & Burman, P. (2013) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0292-x · Cited by 43
Vallecillo, G., Robles, M. J., Torrens, M., Samos, P., Roquer, A., Martires, P. K., Sanvisens, A., Muga, R., & Pedro-Botet, J. (2018) · Substance Abuse · doi:10.1080/08897077.2017.1363122 · Cited by 42
Bartoli, F., Crocamo, C., Caslini, M., Clerici, M., & Carrà, G. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.028 · Cited by 36
Shulman, M., Miller, A., Misher, J., & Tentler, A. (2014) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s49817 · Cited by 34
A combined continuous and interval aerobic training improves metabolic syndrome risk factors in men
Naderali, E. K., Sari-Sarraf, V., Aliasgarzadeh, A., Naderali, M.-M., & Esmaeili, H. R. (2015) · International Journal of General Medicine · doi:10.2147/ijgm.s81938 · Cited by 33
Kemp, D. E., Calabrese, J. R., Tran, Q.-V., Pikalov, A., Eudicone, J. M., & Baker, R. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05159gre · Cited by 33
Wynchank, D., Bijlenga, D., Lamers, F., Kooij, J. J. S., Bron, T. I., Beekman, A. T. F., & Penninx, B. W. J. H. (2016) · Journal of Attention Disorders · doi:10.1177/1087054716659137 · Cited by 24
Self-citation
Research works printed but not linked: 3
- Newcomer JW., 2007, J Clin Psychiatry., 68, 8
- Vallecillo G., SubstAbus. 2017 August 3. Epub ahead of print. doi:10. 1080/08897077.2017.1363122.
- Sari-Sarraf V., 2015, Int J Gen Med., 8, 203
Cited by
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003
Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Nutrients · doi:10.3390/nu15122749 · Cited by 804
McGuinness, A. J., Davis, J. A., Dawson, S. L., Loughman, A., Collier, F., O’Hely, M., Simpson, C. A., Green, J., Marx, W., Hair, C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01456-3 · Cited by 502
“Given the rapidly growing evidence base for the gut microbiota’s influence on multiple systems and pathways that are known to be commonly dysregulated across these mental disorders, including inflammation [15, 16] and oxidative stress [17]; tryptophan metabolism and the kynurenine pathway [18, 19]; mitochondrial dysfu…”
BackgroundFeeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis
Schneider, E., O’Riordan, K. J., Clarke, G., & Cryan, J. F. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01108-6 · Cited by 272
“The high comorbidity between neuropsychiatric and metabolic disorders 124 , coupled with divergences in gut microbiota composition, may be, at least partially, explained by diet-induced effects on gut microbiota signalling to the brain.”
Mazereel, V., Detraux, J., Vancampfort, D., van Winkel, R., & De Hert, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573479 · Cited by 205
Metadata
- Authors
- Penninx, B. W. J. H., & Lange, S. M. M.
- Affiliations
- GGZ inGeest (NL)
- Corresponding author
- Penninx, Brenda W. J. H.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2018-03-31
- Volume
- 20
- Issue
- 1
- Pages
- 63-73
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC6016046
- OpenAlex
- W2920711593
- Cited by
- 566
- References
- 78
- Citations by year
- 2026: 68 · 2025: 100 · 2024: 106 · 2023: 92 · 2022: 64 · 2021: 72 · 2020: 41 · 2019: 18 · 2018: 3
- FWCI
- 26.66
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- metabolic syndrome, mental illness, cardiovascular risk, major depressive disorder, bipolar disorder, schizophrenia, anxiety disorders, attention deficit hyperactivity disorder, post-traumatic stress disorder, abdominal obesity, dyslipidemia, hypertension, hyperglycemia, psychotropic drugs, adverse drug reactions, lifestyle factors, medication adherence, genetic susceptibility, immunometabolism, endocrine system, premature mortality
- MeSH terms
- Mental Disorders, Bipolar Disorder, Major Depressive Disorder, Depressive Disorder, Major, Humans, Psychotropic Drugs, Schizophrenia, Stress Disorders, Post-Traumatic, Metabolic Syndrome, Risk Reduction Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.